K. Bühring

发表

Analysis of the Status of the Cutaneous Endogenous and Exogenous Antioxidative System of Smokers and the Short-Term Effect of Defined Smoking Thereon

R. Sabat, M. Meinke, J. Lademann, 2020, Antioxidants.

Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.

N. Hewitt, D. Utesch, J. Haunschild, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Different Effects of Exercise on Plasma Concentrations of Nebivolol, Bisoprolol and Carvedilol

K. Stoschitzky, W. Lindner, G. Stoschitzky, 2004, Cardiovascular Drugs and Therapy.

Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

H. Wiemann, G. Leopold, K. Bühring, 1986, British journal of clinical pharmacology.

Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa.

W. Mederski, D. Dorsch, B. Cezanne, 2004, Bioorganic & medicinal chemistry letters.

Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.

H. Nowak, K. Steiner, A. Garbe, 1982, Arzneimittel-Forschung.

Determination of the new β-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography

A. Garbe, K. Bühring, 1986 .

Pharmacokinetics and Metabolism of Bisoprolol-14C in Three Animal Species and in Humans

G. Leopold, A. Garbe, K. Bühring, 1985, Journal of cardiovascular pharmacology.

Concentration Kinetics of Propranolol, Bisoprolol, and Atenolol in Humans Assessed with Chemical Detection and a Subtype‐Selective &bgr;‐Adrenoceptor Assay

A. Wellstein, G. Belz, D. Palm, 1985, Journal of cardiovascular pharmacology.

Basic Pharmacokinetics of Bisoprolol, a New Highly Beta1‐selective Adrenoceptor Antagonist

K. Bühring, J. Pabst, Götz Leopold, 1986, Journal of clinical pharmacology.

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer’s Disease—Studies on Relation to Effective Target Occupancy

T. Hoffmann, S. Schilling, H. Demuth, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Metabolism of dihydroaminopterin and the influence of aminopterin and related derivatives on the metabolism of (-)-5-formyl-tetrahydrofolic acid in Pediococcus cerevisiae.

K. Bühring, E. Fölsch, 1976, Biochimica et biophysica acta.

Pharmacokinetics and first clinical experiences with an antihypertensive dopamine (DA2) agonist.

W. Meyer, E. Schnurr, K. Steiner, 1992, European heart journal.

Metabolism of praziquantel in man

H. Nowak, A. Garbe, K. Bühring, 1978, European Journal of Drug Metabolism and Pharmacokinetics.